Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

Gleneagles winning captain outlines the humble origins of the statistical work which will play a big role at Bethpage ...

By Marilyn Odendahl The Indiana Citizen September 4, 2025 At a public meeting held in Indianapolis on Wednesday to discuss ...

In response to the needs of smart campus construction, Xi'an Medical College Library has officially launched a big data display platform, marking a solid step towards the digital and intelligent ...

Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered ...

U.S. INDICATIONS AND USAGE POMBILITI in combination with OPFOLDA is indicated for the treatment of adult patients with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency) ...

Data to be presented in the Immunotherapy & Cell Therapy in Sarcoma: Emerging Frontiers session at the Connective Tissue Oncology Society ...

The September issue of LCGC International delivers new perspectives in oligonucleotide analysis, robust data statistics, and advanced workflows for complex biologics.

NC Child, a nonprofit child advocacy organization, compiled data showing that, in the Cape Fear region, the rates of ...

The Centre on Wednesday defended the constitutional scheme conferring discretion on governors on bills, and said for the last ...

UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...

UWCE's 2026 campaign will be "laser focused" on supporting its Community Fund, and the organization introduced a Community ...